ASCO: Telix tees up pivotal test for Pluvicto challenger while eyeing ‘white space’ on radiopharma canvas – Fierce Biotech
- ASCO: Telix tees up pivotal test for Pluvicto challenger while eyeing ‘white space’ on radiopharma canvas Fierce Biotech
- ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 The Manila Times
- Prostate cancer trial: Telix therapy shows acceptable safety in combo treatment Stock Titan
0
مشاهدة
